Reza Shojaei Asks: What if Your Country Could Stop Depending on Imported Plasma Medicines, Permanently?
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
“What if your country could stop depending on imported plasma medicines, permanently?
For decades, most nations accepted plasma dependency as inevitable. Today, one country has proven that assumption wrong.
Egypt is now one of only a few countries in the world to achieve full national self-sufficiency in essential plasma-derived medicines, including IVIG, albumin, and hemophilia clotting factors. And it didn’t take 50 years to execute once the strategy was right; it took just five.
This transformation was not accidental. It was built through:
- Presidential-level political commitment
- A first-of-its-kind public–private joint venture
- FDA-aligned regulation
- Compensated, medically monitored donors
- And full vein-to-vial industrial integration
In this edition of Blood and Plasma Pulse, we unpack Egypt’s 50-year journey from early failed fractionation attempts to becoming Africa’s first plasma manufacturing hub, and what policymakers, regulators, and health system leaders around the world can learn from it, right now.
If your country is facing:
- IVIG shortages
- Rising plasma medicine costs
- Import dependency
- Or national biologics insecurity
This is not a story you can afford to ignore.”

Read full paper here.
Read more from Reza Shojaei on Hemostasis Today.
-
Aug 11, 2026, 14:16Rayan Ahmed: Master Blood Films and Pathology Online
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan